| Literature DB >> 16106211 |
Judy H Angelbeck1, Girolamo A Ortolano.
Abstract
This article discusses the evidence for the generally accepted uses of leukocyte-reduced blood and the controversy over leukocyte reduction and transfusion-related immunomodulation. A perspective is provided on the continued need for leukocyte reduction on the part of all patients in the United States.Entities:
Mesh：
Substances：
Year: 2005 PMID： 16106211 DOI： 10.1097/00129804-200507000-00010
Source DB: PubMed Journal: J Infus Nurs ISSN： 1533-1458